Work

OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity

Year: 2015

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2015-eular.1428

Authors: J. Smolen, S. Popa, I. Szombati, D. Wallace, M. Petri, P. Lipsky, J. Merrill, V. Strand, P. Healey, C. Li, J. Christensen, A. Diehl, J. Beebe, M. Vincent, J. Wajdula, S. Sridharan

Institutions: Medical University of Vienna, Cedars-Sinai Medical Center, Johns Hopkins University, Ampel BioSolutions (United States), Oklahoma Medical Research Foundation, Stanford University, Pfizer (United States)

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2328268687

Cites:

Cited by: 2

Related to: 10